Skip to main content
Jaroslaw Maciejewski, MD, Hematology, Cleveland, OH

Jaroslaw P Maciejewski MD


Professor of Medicine, Case West Res University

Join to View Full Profile
  • 9500 Euclid AveCleveland, OH 44195

  • Phone+1 800-223-2273

Dr. Maciejewski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1998 - 2000
  • University of Nevada Reno School of Medicine
    University of Nevada Reno School of MedicineResidency, Internal Medicine, 1995 - 1998
  • Humboldt University of Berlin - Charite Faculty of Medicine
    Humboldt University of Berlin - Charite Faculty of MedicineClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2001 - 2026
  • DC State Medical License
    DC State Medical License 2000 - 2002
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes  
    Samuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
  • Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
    Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood

Abstracts/Posters

  • Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Weight-Loss Drugs May Have Surprising Side Effect: Stalling Cancer
    Weight-Loss Drugs May Have Surprising Side Effect: Stalling CancerMay 21st, 2026
  • Cleveland Clinic’s Hemato-Oncology Team Spearheads the Development of Guidelines for Genomic Profiling of MDS to Inform Allo-HCT
    Cleveland Clinic’s Hemato-Oncology Team Spearheads the Development of Guidelines for Genomic Profiling of MDS to Inform Allo-HCTJune 10th, 2025
  • Beta-Thalassemia Gene Tx Gets Ringing Endorsement from FDA Advisers
    Beta-Thalassemia Gene Tx Gets Ringing Endorsement from FDA AdvisersJune 10th, 2022

Grant Support

  • Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid LeukemiaCLEVELAND CLINIC LERNER COM-CWRU2025–2030
  • Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid LeukemiaCLEVELAND CLINIC LERNER COM-CWRU2025–2030
  • Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem CellsCLEVELAND CLINIC LERNER COM-CWRU2022–2027
  • Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem CellsCLEVELAND CLINIC LERNER COM-CWRU2022–2027
  • Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid NeoplasmsCLEVELAND CLINIC LERNER COM-CWRU2021–2026

Other Languages

  • German, Polish, Russian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: